Form 4: Gilead Sciences SVP Sandra Patterson Reports Stock Transactions
SEC Form 4 Filing
Sandra Patterson, SVP, Controllership at Gilead Sciences, reports the vesting and subsequent disposal of restricted stock units.
Summary
- On August 10, 2024, Sandra Patterson, SVP, Controllership at Gilead Sciences, reported transactions involving Gilead Sciences common stock.
- Ms. Patterson exercised 3,678 restricted stock units (RSUs), which converted into an equal number of common stock shares.
- Simultaneously, 980 shares were disposed of at a price of $73.66 per share.
- Following these transactions, Ms. Patterson directly owns 35,976 shares of Gilead Sciences common stock and 14,084 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders trade their company's stock. These filings provide transparency into the transactions of company executives and directors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely negligible.
Key Dates
| Date | Description |
|---|---|
| 08/10/2024 | Date of stock transactions (exercise of RSUs and disposal of shares). |
| 08/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.